The importance of c-kit and PDGF receptors as potential targets for molecular therapy in breast cancerROUSSIDIS, A. E; THEOCHARIS, A. D; TZANAKAKIS, G. N et al.Current medicinal chemistry. 2007, Vol 14, Num 7, pp 735-743, issn 0929-8673, 9 p.Article

p185^BCR/ABL has a lower sensitivity than p210^BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemiaMIAN, Afsar A; METODIEVA, Anna; NAJAJREH, Yousef et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 251-257, issn 0390-6078, 7 p.Article

Optimal treatment of intermediate-risk prostate carcinoma with radiotherapyNICHOL, Alan M; WARDE, Padraig; BRISTOW, Robert G et al.Cancer. 2005, Vol 104, Num 5, pp 891-905, issn 0008-543X, 15 p.Article

Abundant expression of mTOR kinase in salivary gland tumors ― potentials as therapy target?CLAUDITZ, Till Sebastian; GONTAREWICZ, Artur; BOKEMEYER, Carsten et al.Journal of oral pathology & medicine. 2013, Vol 42, Num 10, pp 769-773, issn 0904-2512, 5 p.Article

Molecular construction of bionanoparticles : chimaeric SIV p17-HIV I p6 nanoparticles with minimal viral protein contentCOSTA, Maria J. L; PEDRO, Luisa; ALVES DE MATOS, Antonio P et al.Biotechnology and applied biochemistry. 2007, Vol 48, pp 35-43, issn 0885-4513, 9 p., 1Article

Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibitionKAUSCH, Ingo; HAI JIANG; EWERDWALBESLOH, Nina et al.BJU international (Papier). 2005, Vol 95, Num 3, pp 416-420, issn 1464-4096, 5 p.Article

Novel S-Nitrosothiols Have Potential Therapeutic Uses for Cystic Fibrosis : Cystic Fibrosis: CFTR Modulators and their Mechanism of ActionZAMAN, Khalequz; FRASER-BUTLER, Maya; BENNETT, Deric et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 19, pp 3509-3520, issn 1381-6128, 12 p.Article

RECENT CHANGES IN THE TREATMENT OF PATIENTS WITH ADVANCED LARYNGEAL CANCERGENDEN, Eric M; FERLITO, Alfio; CHEN, Amy Y et al.Head & neck. 2008, Vol 30, Num 1, pp 103-110, issn 1043-3074, 8 p.Article

Modification of apatite materials for bone tissue engineering and drug delivery carriersMATSUMOTO, T; OKAZAKI, M; NAKAHIRA, A et al.Current medicinal chemistry. 2007, Vol 14, Num 25, pp 2726-2733, issn 0929-8673, 8 p.Article

Editorial Neuro AIDS reviewSHAPSHAK, Paul; KANGUEANE, Pandjassarame; NATH, Avindra et al.AIDS (London). 2011, Vol 25, Num 2, pp 123-141, issn 0269-9370, 19 p.Article

No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2QUANTE, Michael; RASKOPF, Esther; STAHL, Sebastian et al.Oncology reports. 2009, Vol 21, Num 5, pp 1161-1168, issn 1021-335X, 8 p.Article

Molecular Targets and Targeted Therapies for Malignant MesotheliomaPALUMBO, Camilla; BEI, Roberto; PROCOPIO, Antonio et al.Current medicinal chemistry. 2008, Vol 15, Num 9, pp 855-867, issn 0929-8673, 13 p.Article

Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholambanFECHNER, H; SUCKAU, L; VETTER, R et al.Gene therapy (Basingstoke). 2007, Vol 14, Num 3, pp 211-218, issn 0969-7128, 8 p.Article

Widespread dispersal of cholera toxin subunit b to brain and spinal cord neurons following systemic deliveryALISKY, Joseph M; VAN DE WETERING, Christopher I; DAVIDSON, Beverly L et al.Experimental neurology (Print). 2002, Vol 178, Num 1, pp 139-146, issn 0014-4886, 8 p.Article

Gene Therapy for Parkinson's and Alzheimer's Diseases: from the Bench to Clinical TrialsJORGE NOBRE, Rui; PEREIRA DE ALMEIDA, Luis.Current pharmaceutical design (Print). 2011, Vol 17, Num 31, pp 3434-3445, issn 1381-6128, 12 p.Article

Molecular therapy for the treatment of hepatocellular carcinomaGRETEN, T. F; KORANGY, F; MANNS, M. P et al.British journal of cancer. 2009, Vol 100, Num 1, pp 19-23, issn 0007-0920, 5 p.Article

Pathogenesis of lung cancer signalling pathways: roadmap for therapiesBRAMBILLA, E; GAZDAR, A.The European respiratory journal. 2009, Vol 33, Num 6, pp 1485-1497, issn 0903-1936, 13 p.Article

The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cellsMANDAL, M; KIM, S; YOUNES, M. N et al.British journal of cancer. 2005, Vol 92, Num 10, pp 1899-1905, issn 0007-0920, 7 p.Article

Investigational agents for epithelial ovarian cancerMUGGIO, Franco; KOSLOFF, Rebecca.Expert review of anticancer therapy. 2005, Vol 5, Num 5, pp 855-868, issn 1473-7140, 14 p.Article

Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markersBELL, Diana; HANNA, Ehab Y.Expert review of anticancer therapy. 2013, Vol 13, Num 3, pp 285-296, issn 1473-7140, 12 p.Article

Enzymatic Single-Chain Antibody Tagging: A Universal Approach to Targeted Molecular Imaging and Cell Homing in Cardiovascular DiseaseTA, H. T; PRABHU, S; WANG, X et al.Circulation research. 2011, Vol 109, Num 4, pp 365-373, issn 0009-7330, 9 p.Article

Malignant gliomas : strategies to increase the effectiveness of targeted molecular treatmentWEN, Patrick Y; KESARI, Santosh; DRAPPATZ, Jan et al.Expert review of anticancer therapy. 2006, Vol 6, Num 5, pp 733-754, issn 1473-7140, 22 p.Article

Molecular therapies in β-thalassaemiaQUEK, Lynn; SWEE LAY THEIN.British journal of haematology. 2007, Vol 136, Num 3, pp 353-365, issn 0007-1048, 13 p.Article

Molecular therapy in support to radiotherapyDUTREIX, M; COSSET, J. M; SUN, J.-S et al.Mutation research. Reviews in mutation research. 2010, Vol 704, Num 1-3, pp 182-189, issn 1383-5742, 8 p.Conference Paper

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageTOVAR, Victoria; ALSINET, Clara; CABELLOS, Laia et al.Journal of hepatology. 2010, Vol 52, Num 4, pp 550-559, issn 0168-8278, 10 p.Article